Publications

Detailed Information

Interaction of Nrf2 with dimeric STAT3 induces IL-23 expression: Implications for breast cancer progression

DC Field Value Language
dc.contributor.authorKim, Su-Jung-
dc.contributor.authorSaeidi, Soma-
dc.contributor.authorCho, Nam-Chul-
dc.contributor.authorKim, Seung Hyeon-
dc.contributor.authorLee, Han-Byoel-
dc.contributor.authorHan, Wonshik-
dc.contributor.authorNoh, Dong-Young-
dc.contributor.authorSurh, Young-Joon-
dc.date.accessioned2022-04-18T02:22:52Z-
dc.date.available2022-04-18T02:22:52Z-
dc.date.created2021-03-09-
dc.date.created2021-03-09-
dc.date.issued2021-03-01-
dc.identifier.citationCancer Letters, Vol.500, pp.147-160-
dc.identifier.issn0304-3835-
dc.identifier.other125073-
dc.identifier.urihttps://hdl.handle.net/10371/178054-
dc.description.abstractPersistent activation of STAT3 and Nrf2 is considered to stimulate the aggressive behavior of basal-like breast cancer (BLBC). However, the precise mechanism underlying sustained overactivation of these transcription factors and their roles in breast cancer progression remain elusive. Analysis of the TCGA multi-omics data showed that high levels of STAT3 and Nrf2 mRNA were correlated with elevated expression of P-STAT3(Y705) and Nrf2 target proteins in breast cancer patients. Our present study demonstrates a unique interaction between Nrf2 and STAT3 in the maintenance and progression of BLBC. RNA sequencing analysis identified the gene encoding IL-23A upregulated by concurrent binding of STAT3 and Nrf2 to its promoter. IL-23A depletion also showed the similar phenotypic changes to those caused by double knockdown of both transcription factors. In conclusion, the STAT3-Nrf2 interaction accelerates BLBC growth and progression by augmenting IL-23A expression, which underscores the importance of subtype-specific molecular pathways in human breast cancer.Y-
dc.language영어-
dc.publisherElsevier BV-
dc.titleInteraction of Nrf2 with dimeric STAT3 induces IL-23 expression: Implications for breast cancer progression-
dc.typeArticle-
dc.contributor.AlternativeAuthor서영준-
dc.contributor.AlternativeAuthor한원식-
dc.contributor.AlternativeAuthor노동영-
dc.identifier.doi10.1016/j.canlet.2020.11.047-
dc.citation.journaltitleCancer Letters-
dc.identifier.wosid000607200800014-
dc.identifier.scopusid2-s2.0-85098155743-
dc.citation.endpage160-
dc.citation.startpage147-
dc.citation.volume500-
dc.identifier.sci000607200800014-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthorHan, Wonshik-
dc.contributor.affiliatedAuthorNoh, Dong-Young-
dc.contributor.affiliatedAuthorSurh, Young-Joon-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.subject.keywordPlusSIGNALING PATHWAY-
dc.subject.keywordPlusGENE-EXPRESSION-
dc.subject.keywordPlusACTIVATION-
dc.subject.keywordPlusCELLS-
dc.subject.keywordPlusPROMOTES-
dc.subject.keywordPlusTRANSCRIPTION-
dc.subject.keywordPlusGROWTH-
dc.subject.keywordPlusINHIBITOR-
dc.subject.keywordPlusCARCINOMA-
dc.subject.keywordPlusTRANSACTIVATION-
dc.subject.keywordAuthorNrf2-
dc.subject.keywordAuthorSTAT3-
dc.subject.keywordAuthorIL-23A-
dc.subject.keywordAuthorBreast cancer-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Pharmacy
  • Department of Pharmacy
Research Area Agricultural Sciences

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share